Wednesday , June 20 2018
Home / Production Assistant, Diabetes In Control (page 60)

Production Assistant, Diabetes In Control

Question #878

Test Your Knowledge

The diabetes drug empagliflozin reduces all of the following CV risk factors except: a. Blood pressure b. Visceral adiposity c. Low-density lipoprotein cholesterol d. Triglycerides e. Atrial stiffness Follow the link to see if you got it right!

Read More »

The Benefits of Motivational Interviewing

Woman, 57 years of age, prediabetes, hyperlipidemia, class I obesity and history of gestational diabetes. I’ve been working with her for the past two years. The first year she was very motivated because of her new diagnosis of prediabetes and her weight being what it was. Her son was getting married and she wanted to lose weight for the wedding. We discussed a plan for her.

Read More »

International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #67: Regulation of Glucose Metabolism in Liver Part 3 of 11

Regulation of glycogenolysis: Glycogen metabolism is regulated by reciprocal changes in the activities of glycogen synthase and glycogen phosphorylase. Net glucose production from glycogen occurs when phosphorylase activity is higher than synthase activity. Activation of glycogen phosphorylase is the culmination of a “glycogenolytic cascade” that is initiated by the binding of glucagon or beta-adrenergic agonists to their receptors in liver cells.

Read More »